Watson launches Generess Fe low-dose oral contraceptives in the U.S.

Watson Pharmaceuticals, Inc., today announced the U.S. commercial launch of Generess Fe 0.8 mg/25 mcg, a new low-dose oral contraceptive option that’s highly effective at preventing and proven to provide users with short, lighter, predictable periods.


Read more

Related posts

Leave a Reply